Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide

British Journal of Radiology

Volumn 86, Issue 1022, 2013, Pages

  Sherriff, J ^a   Tamangani, J ^a   Senthil, L ^a   Cruickshank, G ^a   Spooner, D ^a   Jones, B ^b   Brookes, C ^c   Sanghera, P ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GADOLINIUM; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELLULITIS; CHEMORADIOTHERAPY; DRUG TREATMENT FAILURE; FATIGUE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEART INFARCTION; HEMISPHERE; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PATIENT COMPLIANCE; PNEUMONIA; PROGRESSION FREE SURVIVAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; BRAIN TUMOR; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TREATMENT FAILURE; YOUNG ADULT;

EID: 84873680342     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20120414     Document Type: Article

References (24)

1. Counsell CE, Collie DA, Grant R. Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. J Neurol Neurosurg Psychiatry 1996;61:143-50.
2. Stupp R, Mason WP, Van denBent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
3. Stupp R, Hegi ME, Mason WP, Van denBent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459-66.
4. Burger PC, Dubois PJ, Schold C, Smith KR, Odum GL, Crafts DC, et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 1983;58:159-69.
5. Halperin EC, Bentel G, Heinz ER, Burger PC. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989;17:1347-50.
6. Gasper LE, Fisher BJ, MacDonald DR, Leber DV, Halperin EC, Schold SC, et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys 1992;24:55-7.
7. Gilbert MR, Wang M, Aldape KD, Stupp R, Hegi M, Jaeckle KA, et al. RTOG 0525: a randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose dense (dd) schedule in newly diagnosed glioblastoma (GBM). J Clin Oncol 2011;29 (Suppl.; abstr 2006).
8. rtog. org [homepage on the internet]. Philadelphia, PA: Radiation Therapy Oncology Group; 2011. [cited 12 February 2012]. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx? action5openFile &FileID54664.
9. Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma. Neurology 1980;30: 907-11.
10. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-9.
11. Chang EL, Akyurek S, Avalos T, Rebueno N, Spicer C, Garcia J, et al. Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 2007;68:144-50.
12. Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010;97:377-81.
13. McDonald MW, Shu HG, Curran WJ, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 2011;79:130-6.
14. Brandes AA, Tosoni A, Fransceschi E, Sotti G, Frezza G, Amista P, et al. Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status. J Clin Oncol 2009;27:1275-9.
15. Milano MT, Okunieff P, Donatello RS, Mohile MA, Sul J, Walter KA, et al. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma. Int J Radiat Oncol Biol Phys 2010; 8:1147-55.
16. Lee SW, Fraass BA, Marsh LH, Herbort K, Gebarski SS, Martel MK, et al. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 1999;43:79-88.
17. Lawrence YR, Li XA, El Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 2010;76(Suppl. 3):S20-7.
18. Yan H, Williams Parsons D, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360: 765-73.
19. Fitzek MM, Thornton AF, Rabinov JD, Lev MH, Pardo FS, Munzenrider JE, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999;91:251-60.
20. Creak AL, Tree A, Saran F. Radiotherapy planning in high-grade gliomas: a survey of current UK practice. Clin Oncol (R Coll Radiol) 2011;23:189-98.
21. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 2010;76 (Suppl. 3):S28-35.
22. Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 2010;76(Suppl. 3):S36-41.
23. Davidson MTM, Masucci GL, Follwell M, Blake SJ, Xu W, Moseley DJ, et al. Single arc volumetric modulated arc therapy for complex brain gliomas: is there an advantage as compared to intensity modulated radiotherapy or by adding a partial arc? Technol Cancer Res Treat 2012;11: 211-20.
24. Sanghera P, Rampling R, Haylock B, Jefferies S, McBain C, Rees JH, et al. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas. Clin Oncol (R Coll Radiol) 2012;24:216-27.